相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unintentional weight loss, its associated burden, and perceived weight status in people with cancer
Eva Y. N. Yuen et al.
SUPPORTIVE CARE IN CANCER (2020)
Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
Oleg Blyuss et al.
BRITISH JOURNAL OF CANCER (2020)
GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics
Alexis Parente et al.
FASEB JOURNAL (2020)
Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice
Domiziana Costamagna et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data
Harpreet Kaur et al.
FRONTIERS IN GENETICS (2020)
Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
Keizo Takenaga et al.
PLOS ONE (2020)
Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
Kevin G. Burfeind et al.
ELIFE (2020)
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Tomoko Nakanishi et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia
Surendra K. Shukla et al.
CANCER LETTERS (2020)
Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients
Hong Peng et al.
CANCERS (2020)
Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice
Rowena Suriben et al.
NATURE MEDICINE (2020)
ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia
Joshua R. Huot et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
Kjetil Soreide et al.
JOURNAL OF PANCREATIC CANCER (2020)
Novel molecular targets of muscle wasting in cancer patients
Janice Miller et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2019)
A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis
Reith R. Sarkar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann et al.
CANCERS (2019)
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh M. Griffin et al.
PANCREATOLOGY (2019)
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
Xiaoling Zhong et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Quality of Life and Treatment Outcomes of Patients with Chronic Pancreatitis and Pancreatic Cancer
Edita Bieliuniene et al.
MEDICINA-LITHUANIA (2019)
Modeling Human Cancer-induced Cachexia
Erin E. Talbert et al.
CELL REPORTS (2019)
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A. Michaelis et al.
NATURE COMMUNICATIONS (2019)
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann et al.
CANCERS (2019)
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
Markus Kieler et al.
MEDICAL ONCOLOGY (2019)
Undulating changes in human plasma proteome profiles across the lifespan
Benoit Lehallier et al.
NATURE MEDICINE (2019)
Plasma proteomic signature of age in healthy humans
Toshiko Tanaka et al.
AGING CELL (2018)
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
Olga Prokopchuk et al.
BMC CANCER (2018)
Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
Nora Mattila et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
Nilabja Sikdar et al.
CURRENT GENOMICS (2018)
CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage
Kuan Hu et al.
TRANSLATIONAL ONCOLOGY (2018)
Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
Angie M. Y. Shum et al.
Oncotarget (2018)
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer
Joshua K. Kays et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
Talia Golan et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy
Andrew E. Hendifar et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice
Susan C. Kandarian et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma
A. Miller et al.
ONCOGENE (2017)
The Human Skeletal Muscle Proteome Project: a reappraisal of the current literature
Marta Gonzalez-Freire et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent
C. J. Reddel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions
Laura Nemer et al.
PANCREAS (2017)
Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice
Jacob L. Brown et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia
Ernie D. Au et al.
FRONTIERS IN PHYSIOLOGY (2017)
Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
Andrea Bonetto et al.
FRONTIERS IN PHYSIOLOGY (2017)
Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
Marek Sierzega et al.
BRITISH JOURNAL OF CANCER (2017)
The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
S. Schwarz et al.
BMC CANCER (2017)
Regulation of muscle growth and regeneration by the immune system
James G. Tidball
NATURE REVIEWS IMMUNOLOGY (2017)
PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer
Qiang Yi et al.
TUMOR BIOLOGY (2016)
GDF15 promotes EMT and metastasis in colorectal cancer
Chen Li et al.
ONCOTARGET (2016)
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
Lorena Lerner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia
Claudia A. Penafuerte et al.
BRITISH JOURNAL OF CANCER (2016)
A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy
Qi Qi et al.
CANCER (2016)
Cell death, clearance and immunity in the skeletal muscle
C. Sciorati et al.
CELL DEATH AND DIFFERENTIATION (2016)
STAT3 in the systemic inflammation of cancer cachexia
Teresa A. Zimmers et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Andrea Bonetto et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
Eun Young Kim et al.
PLOS ONE (2016)
Wnt/β-Catenin Signaling Contributes to Skeletal Myopathy in Heart Failure via Direct Interaction With Forkhead Box O
Katsuki Okada et al.
CIRCULATION-HEART FAILURE (2015)
Role of Activin A and Myostatin in Human Cancer Cachexia
Audrey Loumaye et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
Hyeong-Kyu Park et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
Lorena Lerner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration
Alessandra Castiglioni et al.
PLOS ONE (2015)
Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra- Day Variation in Patients with Advanced Pancreatic Cancer
Yutaka Fujiwara et al.
PLOS ONE (2014)
Role of interleukin-6 in cachexia: therapeutic implications
Aditi A. Narsale et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2014)
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
John C. Rohloff et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Cancer cachexia: understanding the molecular basis
Josep M. Argiles et al.
NATURE REVIEWS CANCER (2014)
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
Yhun Yhong Sheen et al.
BIOMOLECULES & THERAPEUTICS (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
Andrea Bonetto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis
Andreas Keller et al.
RNA BIOLOGY (2011)
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
Margaret E. Benny Klimek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
James A. Carson et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2010)
The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer
Ozgur Kemik et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
The role of cytokines in cancer cachexia
Josep M Argilés et al.
Current Opinion in Supportive and Palliative Care (2009)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Pathophysiology of cancer cachexia: Much more than host-tumour interaction?
Richard J. E. Skipworth et al.
CLINICAL NUTRITION (2007)
Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice
Amy L. Moran et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Interleukin 6 is associated with cachexia in patients with prostate cancer
Kenji Kuroda et al.
UROLOGY (2007)
The two faces of IL-6 on Th1/Th2 differentiation
S Diehl et al.
MOLECULAR IMMUNOLOGY (2002)
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
M Wehling et al.
JOURNAL OF CELL BIOLOGY (2001)
分享论文
